ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 621,20
0,66%
Dow Jones
38 778,10
0,00%
DAX
18 129,65
0,31%
Brent Oil
83,855
-0,05%
Bitcoin
64 872,65
-2,43%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Verrica Parmaceuticals Inc (VRCA)

  7. Verrica Parmaceuticals Inc (VRCA) Actualités

VRCA

Verrica Parmaceuticals (VRCA)

Verrica Parmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:VRCA
DateHeureSourceTitreSymboleSociété
10/06/202422h18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VRCAVerrica Parmaceuticals Inc
07/06/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
13/05/202422h31Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VRCAVerrica Parmaceuticals Inc
13/05/202414h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VRCAVerrica Parmaceuticals Inc
29/02/202414h05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VRCAVerrica Parmaceuticals Inc
16/11/202316h28Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:VRCAVerrica Parmaceuticals Inc
15/11/202322h54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VRCAVerrica Parmaceuticals Inc
22/07/202301h28Dow Jones NewsStocks to Watch: AMC Entertainment, Becton Dickinson and Verrica PharmaceuticalsNASDAQ:VRCAVerrica Parmaceuticals Inc
21/07/202323h05Dow Jones NewsVerrica Pharmaceuticals' Molluscum Contagiosum Topical Solution Gets FDA ApprovalNASDAQ:VRCAVerrica Parmaceuticals Inc
12/06/202315h05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VRCAVerrica Parmaceuticals Inc
08/06/202322h17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VRCAVerrica Parmaceuticals Inc
09/05/202314h28Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VRCAVerrica Parmaceuticals Inc
09/05/202314h22Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:VRCAVerrica Parmaceuticals Inc
21/04/202314h57Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VRCAVerrica Parmaceuticals Inc
21/04/202314h51Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:VRCAVerrica Parmaceuticals Inc
21/04/202314h46Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:VRCAVerrica Parmaceuticals Inc
06/03/202315h41Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VRCAVerrica Parmaceuticals Inc
22/02/202322h18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:VRCAVerrica Parmaceuticals Inc
14/02/202320h37Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VRCAVerrica Parmaceuticals Inc
20/12/202212h10Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VRCAVerrica Parmaceuticals Inc
14/11/202212h15TipRanksH.C. Wainwright Remains a Buy on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
11/11/202202h48TipRanksRBC Capital Remains a Hold on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
07/11/202223h23Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:VRCAVerrica Parmaceuticals Inc
07/11/202222h05GlobeNewswire Inc.Verrica Pharmaceuticals Reports Third Quarter 2022 Financial ResultsNASDAQ:VRCAVerrica Parmaceuticals Inc
31/08/202222h30GlobeNewswire Inc.Verrica Pharmaceuticals Announces Participation in the H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:VRCAVerrica Parmaceuticals Inc
12/08/202212h25TipRanksH.C. Wainwright Keeps Their Buy Rating on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
11/08/202222h35TipRanksNeedham Remains a Hold on Verrica Pharmaceuticals (VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
11/08/202213h30GlobeNewswire Inc.Verrica Pharmaceuticals Reports Second Quarter 2022 Financial ResultsNASDAQ:VRCAVerrica Parmaceuticals Inc
05/08/202218h18PR Newswire (US)VRCA SHAREHOLDER ALERT: Jakubowitz Law Reminds Verrica Shareholders of a Lead Plaintiff Deadline of August 5, 2022NASDAQ:VRCAVerrica Parmaceuticals Inc
03/08/202211h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Verrica Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 5, 2022 - (NASDAQ: VRCA)NASDAQ:VRCAVerrica Parmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:VRCA

Dernières Valeurs Consultées

NYSE
RRC
Range Resources
AMEX
DESC
Xtrackers Russell 2000 C...
LSE
87SF
Hsbc Bk. 23
COIN
GGCCCEUR
GramGold Coin
EU
XS2573331837
ABN AMRO International b...
LSE
ANW
Aberdeen New Thai Invest...
BIT
P1TJ75
BNP Paribas Issuance
ASX
XVGHP
Treasury Corporation of ...
USOTC
HRDIL
Here Media (CE)
EU
1ARKW
Leverage
LSE
39GE
Investec Bnk 23
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés